NCT03188445View on ClinicalTrials.gov

Intravenous Iron Isomaltoside Versus Oral Iron Supplementation for Treatment of Iron Deficiency in Pregnancy.

PHASE4CompletedINTERVENTIONAL

Enrollment

201

Participants

Timeline

Start Date

July 11, 2017

Primary Completion Date

June 26, 2020

Study Completion Date

August 18, 2020

Conditions

Iron Deficiency Anemia of Pregnancy

Interventions

DRUG

Iron Isomaltoside 1000

Administered iv

DRUG

ferrous fumarate with ascorbic acid

Oral administration

Trial Locations (1)

Unknown

Phamacosmos Investigational site, Hvidovre

Sponsors

Lead Sponsor

Pharmacosmos A/S

All Listed Sponsors

lead

Pharmacosmos A/S

INDUSTRY